Alyssa Rose Everson, PA-C

Alyssa Everson practices at Minneapolis Clinic of Neurology, Ltd in Minneapolis, Minnesota.

Alyssa Everson's NPI, 1093335796, was assigned on April 22, 2020. Alyssa Everson holds Minnesota license 13348.

Alyssa Everson's primary practice is Minneapolis Clinic of Neurology, Ltd, at 4225 Golden Valley Rd, Minneapolis, MN 55422 in Hennepin County. The practice phone is (763) 588-0661.

Alyssa Everson's primary practice is Minneapolis Clinic of Neurology, Ltd in Minneapolis, Minnesota. Alyssa Everson is also affiliated with M Health Fairview Ridges Hospital. The medical group on file is Minneapolis Clinic of Neurology. Dmand AI also links Alyssa Everson to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alyssa Everson practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Alyssa Everson's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Dmand AI has Alyssa Everson's licenses on file in 2 states: Minnesota and Wisconsin.

CMS counts 103 Medicare patients who saw Alyssa Everson in 2024. The largest group is 65 to 74, with 42 patients. 67% of them have high blood pressure, and 60% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Alyssa Everson's median patient age at 65, with 68% women.

In 2024, Alyssa Everson wrote 444 Medicare Part D claims for 146 patients. 97% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Alyssa Everson for performance year 2024, reported as part of a group. Alyssa Everson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alyssa Everson as offering telehealth.

CMS Open Payments shows 8 general payments to Alyssa Everson from 7 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Axsome Therapeutics, Inc. paid the most, $44.